Research · Sep 3, 2026
[GIS] General Mills Thesis 2026: Cereal Volume Trough Tests Pet Food and Convenience Pivot
General Mills Inc. FY2025 revenue ~$19.5-20.0B (-2 to flat) with adj. EPS ~$4.20-4.40 reflecting continued post-2022-2024 packaged food volume normalization (selected center-store grocery weakness + selected GLP-1 demand impact concerns + selected consumer trade-down) + selected Blue Buffalo pet food integration + selected operational excellence under continued CEO Jeff Harmening. Leading US packaged food company; founded 1856 as Minneapolis Milling Company (Wheaties brand introduced 1924; Cheerios introduced 1941; rebranded General Mills Inc. 1928; IPO 1928); headquartered in Minneapolis Minnesota; ~34,000+ employees across selected ~100+ countries; fiscal year ends ~May. 5 segments: North America Retail 62% ($12B — Cheerios + Honey Nut Cheerios + Lucky Charms + Cinnamon Toast Crunch + Wheaties cereals + Yoplait yogurt + Pillsbury baking + Betty Crocker + Nature Valley + Fiber One snacks + Häagen-Dazs ice cream selected) + Pet 12% ($2.4B — Blue Buffalo natural pet food acquired April 2018 $8B; selected #1 US natural pet food brand; selected ~3-5% organic growth) + North America Foodservice 11% ($2.1B — selected QSR + institutional) + International 12% ($2.4B — Häagen-Dazs ice cream + Old El Paso Mexican + selected Wanchai Ferry) + Other 3% ($0.6B). CEO Jeff Harmening since June 1, 2017 (succeeded Ken Powell CEO 2007-2017 retired; Harmening ex-General Mills President + COO 2014-2017 + ~30-year General Mills career; Yale undergraduate). Key transactions: April 2018 Blue Buffalo Pet Products $8B acquisition (transformational pet food expansion) + June 2024 Yogurt divestment announcement $2.1B North America Yogurt sale to Lactalis + Sodiaal closing 2025 + 2024 Helper hamburger meal divestment + selected Progresso strategic review + 2024 selected layoffs. Capital return: dividend $2.40-2.48/share annual (~125 consecutive year dividend payment since 1898 — selected longest US public company dividend track among S&P 500) + buybacks $0.5-1B; investment-grade A3/BBB credit rating. FY2026 thesis: cereal volume stabilization + Pet (Blue Buffalo) growth + portfolio realignment + capital return. Risks: GLP-1 weight-loss drug demand impact (~10-15 year transition), private label, commodity cost, retailer destocking.